Organization
Kaiser Permanante
1 abstract
Abstract
Evaluation of outcomes between rituximab-abbs and reference product rituximab in adult patients with newly diagnosed diffuse large B-cell lymphoma in a non-inferiority study.Org: Kaiser Permanente Oakland Medical Center, Kaiser Permanante, Kaiser Permanente Davis, Kaiser Permanante Irvine, Kaiser Permanente Pasadena,